Related Experiment Video

Updated: May 18, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Circulating biomarkers

L Badimon1, J C Romero, J Cubedo

  • 1Cardiovascular Research Center, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain. lbadimon@csic-iccc.org

Thrombosis Research
|October 3, 2012
PubMed

Insights

New biomarkers aid in preventing cardiovascular diseases (CVD) by identifying at-risk individuals and monitoring disease progression. This review explores recently discovered CVD biomarkers and their clinical applications for improved diagnosis and prognosis.

Area of Science:

  • Cardiology
  • Biomarker Discovery
  • Preventive Medicine

Background:

  • Cardiovascular diseases (CVD) are a major global cause of mortality.
  • Emerging biomarkers offer potential for primary CVD prevention and risk stratification.
  • Current biomarkers include inflammatory, endothelial, neurohormonal, ischemia, and necrosis markers.

Purpose of the Study:

  • To review recently discovered biomarkers for cardiovascular diseases.
  • To discuss the clinical applications of these novel biomarkers.
  • To highlight the importance of new biomarkers for enhancing CVD diagnosis and prognosis.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of studies on novel cardiovascular biomarkers.
  • Synthesis of information on clinical utility and applications.

Main Results:

  • Several new biomarkers show promise in CVD risk assessment.
  • Biomarkers are crucial for identifying individuals at risk and monitoring disease.
  • Novel markers can improve diagnostic and prognostic accuracy in CVD.

Conclusions:

  • Continued research into novel biomarkers is essential for advancing CVD prevention.
  • Biomarkers play a vital role in personalized cardiovascular risk management.
  • The clinical application of new biomarkers promises to enhance patient outcomes in CVD.

More Related Videos

Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR07:37

Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR

Published on: June 26, 2016

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...